Join NAMSA for this webinar where we will discuss the most common approaches used for determining the exhaustive endpoint, their advantages and disadvantages and their influence on study design and results. We will also outline how regulatory requirements and laboratory execution diverge, as well as other challenges of an E&L study that are influenced by a lack of standardized procedures (e.g. mass balance, toxicological assessment).
Calendar of Events
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
1 event,
–
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
–
Companies performing qualified R&D activities can be rewarded by lucrative federal and state tax incentives in the form of R&D tax credits, even if their efforts were not successful. This is particularly true for small-to-midsized BIO and state life science association members. BIO recently partnered with ADP to provide discounted R&D tax credit services to life science companies. Join us for a complimentary webinar to learn how to maximize this new BIO-ADP tax credit offering. |
1 event,
–
Join OLS and the region’s life sciences community for education and networking, in partnership with J.P. Morgan & Thompson Hine LLP. Attendees will learn about OLS’ direction and focus for 2023 and beyond, and how you can get involved. J.P. Morgan will share an update on the 2023 J.P. Morgan Healthcare Conference and Thompson Hine LLP will provide an overview of life sciences trends. This is a FREE event with drinks and appetizers provided. |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|

